All Breast cancer articles
-
Formulary decision guidePROSTAP® DCS (leuprorelin acetate)
This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd. Information intended for healthcare professionals only.
View prescribing information here
C-APROM/UK/LEU/0075 February 2021 -
Top tips
Top tips: early and locally advanced breast cancer
Dr Richard Simcock and Dr Nicola Harker offer 10 top tips on early breast cancer diagnosis and treatment, based on recent recommendations and research
-
Hot topic
Tools will aid GPs in assessing people with possible cancer
Experts from Macmillan Cancer Support show how tools developed by Macmillan can support GPs in decision making and facilitate earlier diagnosis of suspected cancer
-
Implementing guidelines
Family history is key to risk classification of familial breast cancer
Professors Nadeem Qureshi and Gareth Evans explain how decisions on surveillance and treatment strategies for people with familial breast cancer are based on level of risk
-
Commissioning article
Premature mortality from breast cancer remains a key issue
Dr Karen McEwan describes legislation and guidance that needs to be considered when commissioning services for improved outcomes in women with breast cancer
-
Implementing guidelines
Patient uptake of breast screening should be promoted
Mr Clive Griffith (left) and Dr Wendy Carr explain the role of primary care in managing the side-effects arising from surgery for breast cancer and adjuvant treatment
-
NICE quality standard article
Treatment for breast cancer should not be influenced by age
Patients with breast cancer should be included in decisions on the management of their disease as outlined in the NICE quality standard, says Dr Adrian Harnett
-
Implementing guidelines
GPs have an important role in caring for women with early breast cancer
Professor Malcolm Reed (left) and Mr James Harvey discuss the management and treatment of breast cancer and the increasing role of primary care in the follow up of patients
-
Implementing guidelines
Multidisciplinary teams should manage patients with breast cancer
Dr Chris Gaffney highlights the need for seamless integration between primary and secondary care in the implementation of the NICE guideline on advanced breast cancer
-
Implementing guidelines
Patients with breast cancer can turn to GPs for support
Dr Adrian Harnett discusses the NICE guideline on the diagnosis and treatment of early and locally advanced breast cancer, and outlines the role of primary care
-
Implementing guidelines
Guideline will help GPs provide holistic care to breast cancer patients
New guidance from SIGN should enable GPs to manage the psychological aspects of the disease as well as providing long-term follow-up, says Dr John Donald
-
Implementing guidelines
SIGN notes for discussion with patients and carers: 25. Management of breast cancer in women
25. Management of breast cancer in women
-
Good practice initiative
Local guidance has streamlined referrals to breast clinics
The winning project in the breast referrals category in the 2004 Guidelines in Practice Awards has improved appropriate referrals to diagnostic services and enabled rapid feedback to GPs
-
Implementing guidelines
Guideline will help GPs assess risk of familial breast cancer
The new NICE guideline will enable GPs to determine which women with a family history of breast cancer are at increased risk and should be referred, says Dr Jon Emery
-
Implementing guidelines
Guideline will help GPs advise women on breast cancer risk
NICE has produced useful recommendations for GPs on managing women with a family history of breast cancer, says Dr John Donald
-
Good practice initiative
Integrated breast care pathway streamlines the referral process
Mr Nick Carty explains how a scheme to involve GPs in the assessment of patients with breast symptoms has helped prioritise referrals and improve patient care
-
Implementing guidelines
Updating national guidelines for referral of breast problems
Professor Robert Mansel (left), Dr Nader Khonji and Mr Dayalan Clarke explain how the revised guidelines aim to allow fast-tracking of patients with suspected cancer
